Innovators in mass spectrometry-based proteomics and bioinformatics, applied to biomarker development and the study of neurodegeneration
Joined July 2019
- Tweets 9
- Following 68
- Followers 335
- Likes 2
2 Photos and videos
14 Dec 2020
Thank you @alzforum for writing such a wonderful article on our recent Cell publication where we mapped distinct post translational modifications for Tau in AD.
#alzforum #medicine #alzheimersdisease #tau #dementia #aging #therapeutics #biomarkers
alzforum.org/news/research-n…
2
9
7 Dec 2020
We are thrilled that our FLEXIQuant-LF paper has been accepted @eLife. This software maps and quantifies post translationally modified peptides without the use of heavy labelled standards. This expands FLEXIQuant to label-free large-scale proteomics data.elifesciences.org/articles/5…
1
4
17
30 Nov 2020
Thank you @ravenscimaven for your music. It’s on repeat in our lab, helping our students understand the immune system like never before!
2
19
16 Nov 2020
Excited to share our study published in @CellCellPress. In this manuscript we show how the different stages of #Alzheimer's Disease in the human brain are reflected in the chemistry of #Tau protein, which is associated with cognitive decline.
authors.elsevier.com/a/1c3w3…
1
1
11
16 Nov 2020
Congratulations to current and previous members of the lab. @BCH, @harvardmed, @FMKirbyNeuro, @RCFNeuro, @ionicwoman
1
4
16 Nov 2020
The Steen lab has just started working on organizing the first 1000 COVID-19 plasma samples here at Boston Children’s Hospital, part of a large NIAID sponsored IMPACC study on SARS-CoV-2. @hipcproject @PrecVaccines @EPICVaccines #COVID19 #BCH
1
6
19
9 Nov 2020
We are happy to announce that our paper on the plasma proteome during the first week of life has been published in Frontiers in Immunology! We want to thank everyone involved in this great project: @PrecVaccines, @EPICVaccines
frontiersin.org/articles/10.…
1
6
17
25 Jul 2019
The Steen lab is now on Twitter! Follow us to find out about the lab, current projects, and science at the intersections of bioinformatics, mass spectrometry, high throughput proteomics, biomarker development, and neurodegenerative disorders
14
14